DGAP-News: Alphaform AG: Preliminary figures for the first six months of 2012
(firmenpresse) - DGAP-News: Alphaform AG / Key word(s): Half Year Results/Change in
Forecast
Alphaform AG: Preliminary figures for the first six months of 2012
23.07.2013 / 16:28
---------------------------------------------------------------------
Press release
Preliminary figures for the first six months of 2013:
Alphaform feels the economical break
Forecast for the business year 2013 is adjusted downwards
Revenue decreases by 10.5 % to EUR 12.6 million compared to previous
year
Group result within the first six months considerably deteriorated to EUR
-1.1 million
Feldkirchen, 23rd July 2013 - Alphaform AG, a specialist in 3D-printing and
one of the leading companies in the production of orthopaedic implants and
instruments, today announced a downwards adjusted forecast for the current
business year. Due to cyclical customer retention and increasing price
pressure the company decided to adjust downwards its previous revenue
forecast for the business year from EUR 27 to 29 million to EUR 26.5
million. Earnings after taxes are expected to be slightly negative contrary
to the previous forecast of EUR 0.8 million. The company emphasizes that
the revised forecast solely reflects existing business and economic
development. Speculative business opportunities due to new areas and
technologies like 3D Printing or laser-sintered implants, which are
strongly stressed by the company, were not considered in the forecast.
Alphaform revenue decreased in the first six months of 2013 by 10.5 % to
EUR 12.6 million compared to the same period of the previous year (first
six months in 2012: EUR 14.1 million). Net result of the first six months
declined from EUR 0.4 million in 2012 to EUR -1.1 million in 2013. In
addition to the mentioned negative economic influences and price reductions
hereby the non-recurring expenses for the extension of the 3D-printing
sector as well as a more sustainable production is reflected. If only
considering the second quarter, a clearly increasing order income since May
can be registered, especially in the industrial 3D-printing sector.
The Alphaform share registered a loss per share of EUR -0.20 per share
within the first six months of 2013; in the first six months of 2012 this
merit lay at a profit of EUR 0.07 per share.
Retention concerning automotive manufacturers
The 3D printing sector as well as additive manufacturing suffered from
cyclically weak demands. The manufacture of prototypes for the automotive
industry, which is still very important for Alphaform, clearly declined
within the first four months of the year. Especially our main customers
ordered more cautiously. However, since May the situation improved
considerably and order income is even very satisfying since June.
Altogether, the recessive business activity complicates the forecast
concerning the further development. Within the past months, the demand on
laser-sintered products was clearly increasing. In our opinion, this trend
is firm, and therefore we started running an additional production unit in
June. In the same time the whole additive manufacturing sector was
restructured, its start-up costs of EUR 0.25 million were booked in the
second quarter as well. Should the 3D-printing demand on customer side
further increase, we will additionally extend our production capacity in
order to cope with the customer demand in this sector. Furthermore we took
steps to improve the production efficiency by optimized material usage and
automated processes.
Price decline within Medical Division
Within the Alphaform Medical Division considerable market influences were
perceptible, too. Temporarily, orders could only be recieved by giving
considerable price reductions, which more than compensated our efficiency
profits we still achieve. In the second quarter we though experienced a
slight business recovery, which continues until now. We therefore are
confident that the Medical Division will at least stay firm in the further
course of the year. Our laser-sintering pilot-facility for 3D-printing of
metal implants could have positive impacts in the near future.
The development of our foreign subsidiaries in Scandinavia and Great
Britain is positive. In the first six months of 2013 a slightly profitable
growth of 2.0 % in all sections could be achieved.
Key figures of the Alphaform Group
In million EUR 2nd 2nd Cha- 1st 1st Cha-For further informations concerning business development in the first six
quarter quarter nge half half nge
2013 2012 in % 2013 2012 in %
Revenues 6.041 7.329 -17.6 12.608 14,083 -10.5
EBITDA -0.636 0.615 -203.4 -0.288 1,161 -124.8
Operating result -0.945 0.289 -427.0 -0.892 0,508 -275.6
Earnings after taxes -1.031 0.235 -538.7 -1.067 0,387 -375.7
Earnings per share -0.19EUR 0.04EUR -575.0 -0.20EUR 0,07EUR -385.7
Equity as at 30th June 11.722 12,631 -8.3
Total assets as of 30th 20.263 20,485 -5.2
June
Free cash equivalents as at 0.896 1,142 -45.1
30th of June (2012 as at 31st
of Dec.)
Employees in the Group as at 227 231 -1.7
30th of June
months of business year 2013 we refer to the Interim Report 2nd Quarter of
the company, which will be released on 9th August 2013.
About Alphaform
Alphaform AG, based in Feldkirchen near Munich and founded in 1996, is a
production company for complex components and products produced in small
batches. Alphaform belongs to the European market leaders in 3D-printing
for prototyping and to the production of series closer prototypes,
particularly for the automotive and capital goods industries. The company
has a leading position throughout Europe in manufacturing orthopaedic
implants and instruments. The Alphaform share is listed in the Prime
Standard Segment of the Frankfurt Stock Exchange (FWB) under the
abbreviation ATF.
The core competence of Alphaform lies in its extensive application know-how
for processes and materials for the 3D-printing of complex prototypes,
tools, individual components and small series made of plastics and metal.
The company's activity is focused on the orthopaedic and medical
technology, automotive, aviation and aerospace industries. The subsidiaries
of Alphaform are located in Germany, Finland, Sweden and the UK.
Contact:
Dr. Thomas Vetter, CEO Tel.: +49 89 905002 21
ALPHAFORM AG Fax: +49 89 9050021021
Kapellenstraße 10 e-mail: tvetter(at)alphaform.de
85622 Feldkirchen Internet: www.alphaform.de
End of Corporate News
---------------------------------------------------------------------
23.07.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Alphaform AG
Kapellenstraße 10
85622 Feldkirchen
Germany
Phone: +49 (0)89 905002 - 0
Fax: +49 (0)89 905002 - 90
E-mail: ir(at)alphaform.de
Internet: www.alphaform.de
ISIN: DE0005487953
WKN: 548795
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
222544 23.07.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
" alt="Aroway Energy Inc. Increases Proved Reserves by 246%
Datum: 23.07.2013 - 16:28 Uhr
Sprache: Deutsch
News-ID 280959
Anzahl Zeichen: 9609
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 302 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Alphaform AG: Preliminary figures for the first six months of 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
Alphaform AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
